Aigh Capital Management LLC Processa Pharmaceuticals, Inc. Transaction History

Aigh Capital Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 10, 2022	SELL	$4.03 - $8.42 $336,077 - $702,177	-83,394 Reduced 21.54%	303,703 $1.49 Million
Q1 2021 May 13, 2021	BUY	$5.96 - $13.15 $2.31 Million - $5.09 Million	387,097 New	387,097 $4.01 Million

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.